CPI-17 Antikörper

Produktnummer ABIN306457

Produktdetails anti-CPI-17 Antikörper

Target: CPI-17 (PPP1R14A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14A (PPP1R14A))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CPI-17 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Aufreinigung: The antibody was purified from mouse ascitic fluids by protein-G affinity chromatography

Immunogen: Recombinant human PPP1R14A (1-147aa), Accession / GI number: NP_150281

Klon: 4H10

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Recommended dilution 1:500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1mg/ml

Buffer: In Phosphate-Buffered Saline (pH7.4) with 0.1% Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu CPI-17

Target: CPI-17 (PPP1R14A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14A (PPP1R14A))

Andere Bezeichnung: PPP1R14A (PPP1R14A Produkte)

Synonyme: MGC81874 antikoerper, cpi-17 antikoerper, ppp1inl antikoerper, CPI-17 antikoerper, im:7147597 antikoerper, ppp1r14a antikoerper, zgc:110700 antikoerper, PPP1R14A antikoerper, CPI17 antikoerper, PPP1INL antikoerper, Cpi17 antikoerper, 1110001M11Rik antikoerper, protein phosphatase 1 regulatory inhibitor subunit 14A L homeolog antikoerper, protein phosphatase 1 regulatory inhibitor subunit 14A antikoerper, protein phosphatase 1, regulatory (inhibitor) subunit 14Aa antikoerper, protein phosphatase 1, regulatory (inhibitor) subunit 14A antikoerper, ppp1r14a.L antikoerper, ppp1r14a antikoerper, ppp1r14aa antikoerper, PPP1R14A antikoerper, Ppp1r14a antikoerper

Hintergrund: PPP1R14A (Protein phosphatase 1 regulatory subunit 14A) is a phosphorylation-dependent inhibitory protein for smooth muscle myosin phosphate. Myosin phosphatase can reverse MYL (myosin light chain) phosphorylation to induce a state of relaxation. However, during agonist-induced contraction at constant Ca2+ concurrent inhibition of myosin phosphatase leads to increases in MYL phosphorylation and tension. These calcium-independent increases in myosin phosphorylation and tension are termed calcium sensitization. Concentration: 1 mg/ml